98 related articles for article (PubMed ID: 32087594)
1. Plasma level of interleukin-18 and complicated course of febrile neutropenia in hematological patients after intensive chemotherapy.
Korpelainen S; Hämäläinen S; Vänskä M; Koivula I; Pulkki K; Jantunen E; Juutilainen A; Purhonen AK
Cytokine; 2020 May; 129():155021. PubMed ID: 32087594
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia.
Korpelainen S; Intke C; Hämäläinen S; Jantunen E; Juutilainen A; Pulkki K
Dis Markers; 2017; 2017():9805609. PubMed ID: 28845081
[TBL] [Abstract][Full Text] [Related]
3. Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients.
Lappalainen M; Hämäläinen S; Juutilainen A; Koivula I; Pulkki K; Jantunen E
Scand J Clin Lab Invest; 2017 Apr; 77(2):130-134. PubMed ID: 28218011
[TBL] [Abstract][Full Text] [Related]
4. Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients.
Koizumi Y; Shimizu K; Shigeta M; Okuno T; Minamiguchi H; Kito K; Hodohara K; Yamagishi Y; Andoh A; Fujiyama Y; Mikamo H
BMC Infect Dis; 2017 Jan; 17(1):27. PubMed ID: 28056845
[TBL] [Abstract][Full Text] [Related]
5. IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients.
Vänskä M; Koivula I; Jantunen E; Hämäläinen S; Purhonen AK; Pulkki K; Juutilainen A
Cytokine; 2012 Dec; 60(3):787-92. PubMed ID: 22902948
[TBL] [Abstract][Full Text] [Related]
6. A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia.
Luz Fiusa MM; Costa-Lima C; de Souza GR; Vigorito AC; Penteado Aranha FJ; Lorand-Metze I; Annichino-Bizzacchi JM; de Souza CA; De Paula EV
Crit Care; 2013 Aug; 17(4):R169. PubMed ID: 23915833
[TBL] [Abstract][Full Text] [Related]
7. Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia.
Intke C; Korpelainen S; Lappalainen M; Vänskä M; Hämäläinen S; Pulkki K; Jantunen E; Juutilainen A; Purhonen AK
Clin Exp Med; 2022 Feb; 22(1):83-93. PubMed ID: 34255216
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy.
Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Ugai T; Kusuda M; Kameda K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Tanihara A; Kanda Y
Infect Dis (Lond); 2017 Oct; 49(10):748-757. PubMed ID: 28631944
[TBL] [Abstract][Full Text] [Related]
9. Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hours.
Mato AR; Luger SM; Heitjan DF; Mikkelsen ME; Olson E; Ujjani C; Jacobs S; Miltiades AN; Shah P; Schuster SJ; Carroll M; Chauffe AD; Fuchs BD
Cancer Biol Ther; 2010 Apr; 9(8):585-9. PubMed ID: 20160493
[TBL] [Abstract][Full Text] [Related]
10. Human plasma cell-free DNA as a predictor of infectious complications of neutropenic fever in hematological patients.
Purhonen AK; Juutilainen A; Vänskä M; Lehtikangas M; Lakkisto P; Hämäläinen S; Koivula I; Jantunen E; Pulkki K
Infect Dis (Lond); 2015 Apr; 47(4):255-9. PubMed ID: 25664374
[TBL] [Abstract][Full Text] [Related]
11. Pentraxin 3 predicts complicated course of febrile neutropenia in haematological patients, but the decision level depends on the underlying malignancy.
Juutilainen A; Vänskä M; Pulkki K; Hämäläinen S; Nousiainen T; Jantunen E; Koivula I
Eur J Haematol; 2011 Nov; 87(5):441-7. PubMed ID: 21676033
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between procalcitonin serum levels and complications and outcome of patients with hematological malignancy admitted to Intensive Care Unit].
Ferrà C; Lacoma A; García O; Marcos P; Domínguez J; Ribera JM
Med Clin (Barc); 2012 Apr; 138(9):385-8. PubMed ID: 22257606
[TBL] [Abstract][Full Text] [Related]
13. Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics.
Lappalainen M; Jokkala J; Juutilainen A; Hämäläinen S; Koivula I; Jantunen E; Hanhineva K; Pulkki K
Dis Markers; 2018; 2018():6964529. PubMed ID: 29849825
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
[TBL] [Abstract][Full Text] [Related]
15. The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies.
Calik S; Ari A; Bilgir O; Cetintepe T; Yis R; Sonmez U; Tosun S
Saudi Med J; 2018 Sep; 39(9):878-885. PubMed ID: 30251730
[TBL] [Abstract][Full Text] [Related]
16. Use of inflammatory molecules to predict the occurrence of fever in onco-hematological patients with neutropenia.
Ribeiro AF; Nobre V; Neuenschwander LC; Teixeira AL; Xavier SG; Paula FD; Teixeira MM; Teixeira JC; Bittencourt H
Braz J Med Biol Res; 2013 Feb; 46(2):200-6. PubMed ID: 23369970
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non-Hodgkin lymphoma (NADIR study).
Wolff T; Schulz H; Losem C; Reichert D; Hurtz HJ; Sandner R; Harde J; Grebhardt S; Potthoff K; Mueller U; Fietz T
Eur J Haematol; 2019 Feb; 102(2):174-181. PubMed ID: 30347466
[TBL] [Abstract][Full Text] [Related]
18. [Impact of early lymphopenia on the risk of febrile neutropenia and hematological toxicity].
Ben Nasr S; Zriba S; Kacem K; Yahyaoui Y; El Benna H; Mansouri R; Ben Lakhal R; Meddeb B
Tunis Med; 2015 May; 93(5):283-6. PubMed ID: 26578043
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-5, interleukin-6, interleukin-8 and tumour necrosis factor-alpha levels obtained within 24-h of admission do not predict high-risk infection in children with febrile neutropenia.
Aggarwal R; Bansal D; Bansal F; Nanda N; Ray P; Trehan A; Marwaha RK
Indian J Med Microbiol; 2013; 31(3):226-9. PubMed ID: 23883706
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae infection causing septic shock in cancer patients with chemotherapy-induced febrile neutropenia.
Kim YJ; Jung SM; Kang J; Ryoo SM; Sohn CH; Seo DW; Lim KS; Huh JW; Kim SH; Kim WY
Intern Emerg Med; 2019 Apr; 14(3):433-440. PubMed ID: 30600529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
